← Leaderboards
William Marston Linehan
Clinical Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Renal Carcinoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$97,125,175
- Ian M Thompson · University Of Texas Hlth Sci Ctr San Ant$23,354,043
- John James McNeil · Hennepin Healthcare Research Institute$22,201,424
- John H Sampson · Duke University$19,179,772
- William G Kaelin · Dana-Farber Cancer Institute$18,573,699
- Richard H Grimm · University Of Minnesota Twin Cities$17,709,591
Research focus
Renal CarcinomaAffectKidney NeoplasmsFamilyPapillaryInheritedTumorRenal Cell CarcinomaOncogenesGenesVhl GeneAmericanPathway InteractionsMutationFoundationsClear CellHistologyNew AgentsCancer TypeUrologic OncologySyndromeUnited States National Institutes Of HealthClinical TrialsMalignant Neoplasms
Grant awards (101)
Urologic Oncology Branch Consult Core$3,473,915
ZID · FY2025 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene$2,605,436
ZIA · FY2025 · CA · contact PI
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer$1,476,414
ZIA · FY2025 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene$694,782
ZIA · FY2025 · CA · contact PI
Clinical Nursing and Data Management Core$434,240
ZID · FY2025 · CA · contact PI
Urologic Oncology Branch Consult Core$3,679,130
ZID · FY2024 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene$2,759,348
ZIA · FY2024 · CA · contact PI
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer$1,563,629
ZIA · FY2024 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene$735,826
ZIA · FY2024 · CA · contact PI
Clinical Nursing and Data Management Core$459,892
ZID · FY2024 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene$2,861,642
ZIA · FY2023 · CA · contact PI
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer$1,907,762
ZIA · FY2023 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene$953,880
ZIA · FY2023 · CA · contact PI
Clinical Nursing and Data Management Core$545,075
ZID · FY2023 · CA · contact PI
Urologic Oncology Branch Consult Core$545,075
ZID · FY2023 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene$2,856,790
ZIA · FY2022 · CA · contact PI
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer$1,904,526
ZIA · FY2022 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene$952,264
ZIA · FY2022 · CA · contact PI
Clinical Nursing and Data Management Core$544,151
ZID · FY2022 · CA · contact PI
Urologic Oncology Branch Consult Core$544,151
ZID · FY2022 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene$2,250,064
ZIA · FY2021 · CA · contact PI
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer$1,500,042
ZIA · FY2021 · CA · contact PI
Urologic Oncology Branch Consult Core$1,500,042
ZID · FY2021 · CA · contact PI
Clinical Nursing and Data Management Core$1,500,042
ZID · FY2021 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene$750,022
ZIA · FY2021 · CA · contact PI
Urologic Oncology Branch Consult Core$3,444,460
ZID · FY2020 · CA · contact PI
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer$1,530,871
ZIA · FY2020 · CA · contact PI
Clinical Nursing and Data Management Core$1,530,871
ZID · FY2020 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene$765,435
ZIA · FY2020 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene$382,718
ZIA · FY2020 · CA · contact PI
Urologic Oncology Branch Consult Core$2,473,714
ZID · FY2019 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene$1,413,551
ZIA · FY2019 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene$1,413,551
ZIA · FY2019 · CA · contact PI
Clinical Nursing and Data Management Core$1,060,163
ZID · FY2019 · CA · contact PI
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer$706,775
ZIA · FY2019 · CA · contact PI
Urologic Oncology Branch Consult Core$2,171,793
ZID · FY2018 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene$1,241,024
ZIA · FY2018 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene$1,241,024
ZIA · FY2018 · CA · contact PI
Clinical Nursing and Data Management Core$930,769
ZID · FY2018 · CA · contact PI
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer$620,513
ZIA · FY2018 · CA · contact PI
Urologic Oncology Branch Consult Core$2,490,181
ZID · FY2017 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene$1,422,960
ZIA · FY2017 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene$1,422,960
ZIA · FY2017 · CA · contact PI
Clinical Nursing and Data Management Core$1,067,221
ZID · FY2017 · CA · contact PI
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer$711,481
ZIA · FY2017 · CA · contact PI
Urologic Oncology Branch Consult Core$2,631,851
ZID · FY2016 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene$1,503,914
ZIA · FY2016 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene$1,503,914
ZIA · FY2016 · CA · contact PI
Clinical Nursing and Data Management Core$1,127,936
ZID · FY2016 · CA · contact PI
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer$751,958
ZIA · FY2016 · CA · contact PI
Urologic Oncology Branch Consult Core$2,514,751
ZID · FY2015 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene$1,437,001
ZIA · FY2015 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene$1,437,001
ZIA · FY2015 · CA · contact PI
Clinical Nursing and Data Management Core$1,077,750
ZID · FY2015 · CA · contact PI
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer$718,501
ZIA · FY2015 · CA · contact PI
Urologic Oncology Branch Consult Core$2,543,102
ZID · FY2014 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene$1,453,201
ZIA · FY2014 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene$1,453,201
ZIA · FY2014 · CA · contact PI
Clinical Nursing and Data Management Core$1,089,901
ZID · FY2014 · CA · contact PI
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer$726,601
ZIA · FY2014 · CA · contact PI
Urologic Oncology Branch Consult Core$3,061,855
ZID · FY2013 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene$1,749,632
ZIA · FY2013 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene$1,749,632
ZIA · FY2013 · CA · contact PI
Clinical Nursing and Data Management Core$1,312,223
ZID · FY2013 · CA · contact PI
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer$874,817
ZIA · FY2013 · CA · contact PI
Urologic Oncology Branch Consult Core$2,650,885
ZID · FY2012 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene$1,514,792
ZIA · FY2012 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene$1,514,792
ZIA · FY2012 · CA · contact PI
Clinical Nursing and Data Management Core$1,136,093
ZID · FY2012 · CA · contact PI
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer$757,396
ZIA · FY2012 · CA · contact PI
Urologic Oncology Branch Consult Core$2,613,187
ZID · FY2011 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene$1,493,250
ZIA · FY2011 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene$1,493,250
ZIA · FY2011 · CA · contact PI
Clinical Nursing and Data Management Core$1,119,937
ZID · FY2011 · CA · contact PI
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer$746,625
ZIA · FY2011 · CA · contact PI
Consult Core$2,562,624
ZID · FY2010 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene$1,464,356
ZIA · FY2010 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene$1,464,356
ZIA · FY2010 · CA · contact PI
Clinical Nursing and Data Management Core$1,098,267
ZID · FY2010 · CA · contact PI
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer$732,178
ZIA · FY2010 · CA · contact PI
Consult Core$2,091,450
ZID · FY2009 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene$1,394,300
ZIA · FY2009 · CA · contact PI
Clinical Nursing and Data Management Core$1,394,300
ZID · FY2009 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene$1,394,300
ZIA · FY2009 · CA · contact PI
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer$697,151
ZIA · FY2009 · CA · contact PI
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer$1,425,659
Z01 · FY2008 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene$1,425,659
Z01 · FY2008 · CA · contact PI
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene$1,425,659
Z01 · FY2008 · CA · contact PI
Clinical Nursing and Data Management Core$855,395
Z01 · FY2008 · CA · contact PI
Consult Core$570,263
Z01 · FY2008 · CA · contact PI
Molecular Genetics of Kidney Cancer$4,017,873
Z01 · FY2007 · CA · contact PI
Molecular Genetics of Kidney Cancer$0
Z01 · FY2006 · SC · contact PI
Molecular Genetics of Kidney Cancer$0
Z01 · FY2005 · SC
Molecular Genetics of Kidney Cancer$0
Z01 · FY2004 · SC
Molecular Genetics of Kidney Cancer$0
Z01 · FY2003 · SC
Molecular Genetics of Prostate Cancer$0
Z01 · FY2002 · SC
Molecular Genetics of Kidney Cancer$0
Z01 · FY2002 · SC
Molecular Genetics of Prostate Cancer$0
Z01 · FY2001 · SC
Molecular Genetics of Kidney Cancer$0
Z01 · FY2001 · SC
Molecular Genetics of Prostate Cancer$0
Z01 · FY2000 · SC
Molecular Genetics of Kidney Cancer$0
Z01 · FY2000 · SC